Latest Commercial Agreements News

NH3 Clean Energy’s WAH2 project is projected to deliver substantial economic and environmental benefits, including a $7.3 billion GDP uplift and 13.5 million tonnes of CO2 emissions avoided, underpinning its push for government-backed concessional financing.

Horseshoe Metals has unveiled a new copper Exploration Target of up to 3.6 million tonnes at its Motters Zone, while advancing Direct Shipping Ore operations supported by strong copper prices and precious metals credits.

Future Metals has trimmed pre-production capital for its Panton PGM Project by approximately A$74 million through an independent engineering assessment of the Savannah processing facility. Further savings are possible by shifting crushing and ore sorting to Panton, while rising platinum group metal prices bolster project economics.

eMetals Limited has solidified its foothold in high-grade tungsten with a binding acquisition in Utah, while its Ugandan gold projects reveal promising soil anomalies amid ongoing exploration.

GCM Corporation finalises exclusive rights to its Very High Density technology, launches its first commercial heat sink products, and expands global prototyping efforts targeting high-growth sectors including EV infrastructure and data centres.

LTR Pharma has wrapped up recruitment for its SPONTAN Phase II pharmacokinetic study, with interim results expected soon to bolster FDA approval efforts. Meanwhile, US commercial talks for ROXUS advance cautiously under the FDA 503(a) personalised medicine pathway.

NH3 Clean Energy has marked strong progress in its WAH2 clean ammonia project by appointing Linde Engineering for FEED and securing a 15-year water supply agreement, setting the stage for a final investment decision by year-end.

Firebird Metals has locked in exclusive global rights to key LMFP patents through 2045 and commissioned lithium-manganese-rich cathode equipment, progressing its Australian Demonstration Plant with a $2 million ARENA grant.

Structural Monitoring Systems Plc reported a 55% jump in quarterly free cash flow to $1.4 million and eliminated its bank debt by repaying a C$0.8 million term loan. The company also launched the MTP138 radio targeting offshore markets and secured key certifications for its avionics products.

Memphasys Limited has marked a milestone quarter with revenue surpassing A$100,000, driven by repeat orders and multi-year contracts, signalling its transition to a commercially focused biotech business.

Botanix Pharmaceuticals has agreed to terms with Piramal to establish an alternate supplier for the active ingredient in Sofdra, aiming to reduce costs by up to 40% and strengthen its supply chain.

International Graphite Limited (ASX: IG6) and ALKEEMIA have achieved graphite purification exceeding 99.9% total graphitic carbon across diverse concentrate samples, reinforcing their joint venture plans to build a major processing hub in Italy.